One of the most notable computer companies on the planet, IBM, has recently gained fame for the performance of its highly intelligent computer known as "Watson." Now, as Forbes reports, Watson is getting put to the test of looking for brain tumors.
Used in conjunction with efforts from the New York Genome Center, the project is intended to try and prevent these dangerous conditions from developing.
The process will reportedly involve the analysis of genes and other scientific information as a way of using this data more effectively. The piece quotes from research director Ajay Royyuru on the way that Watson can serve as a supplement to the sort of work that researchers normally do on their own.
"We are experts in what we know," Royyuru says. "But we are not experts in what we don't know." He goes on to say that Watson could offer "enormous evidence to the expert that will help the expert function in a faster better manner."
The cloud offerings that Watson could bring to its users are being emphasized by the company as of late: as a recent piece in Wired noted, the business has attempted to devote a billion dollars just to build up this system's functionality, and it is also investigating the potential for extensive mobile application support.
With the concern surrounding BYOD healthcare policies and the way forward for electronic medical systems, big advancements like this could open up new doors to practices. But without the expertise of healthcare IT consulting professionals, you take the risk of making decisions that could come back to haunt you. Looking at the consequences of programs like this could be a guide to proper standards of practice later on.